We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Fluoro-Chromatic Imaging Cytometer

By Biotechdaily staff writers
Posted on 25 Aug 2004
A new cytometer allows simultaneous analysis of fluorescent and chromatically stained specimens. More...
The cytometer was introduced at the Drug Discovery Technology World Congress in Boston (MA, USA) in August 2004.

The new instrument, called iColor, combines the advantages of flow cytometry, fluorescence image analysis, and immunohistochemistry in one system. Traditionally, flow cytometers have relied solely on measurements obtained from laser excitement of cellular specimens stained with fluorescent dyes. The iColor instrument employs three lasers to simultaneously measure both fluorescent light emitted by specimens stained with fluorescent dyes and the light absorbance resulting from the application of chromatic stains to the same specimens. The resulting data and images provide detailed quantitative and morphologic information that previously would have required the use and expense of two or three different systems.

The iColor is expected to be of particular value for pathology applications in research, drug discovery, and drug safety assessment, where chromatic stains are commonly used. The instrument was developed by CompuCyte Corp. (Cambridge, MA, USA).

"The ability to objectively measure both fluorescence and chromatic signals on tissue sections, cell cultures, and other cell preparations constitutes a milestone advance for oncology and pathology,” said Richard Clatch, M.D., Ph.D., director of hematopathology at Lake Forest Hospital (Lake Forest, IL, USA). "We finally have an instrument that combines the advantages of flow cytometry and image analysis.”



Related Links:
CompuCyte

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.